HOME >> MEDICINE >> NEWS
Orqis receives FDA approval to expand clinical trial of Cancion CRS therapy to 40 centers

Orqis Medical Corp. today announced that the U.S. Food and Drug Administration has approved an expansion of the Cancion CRSTM clinical trial from eight to 40 medical centers nationwide, accelerating the trial's recruitment and enrollment efforts.

The Cancion CRS therapy is a percutaneous cardiac recovery system being studied for its ability to create a "rest-to-recovery" environment for congestive heart failure (CHF) patients. Enrollment in the Multicenter trial of the Orqis Medical CRS for the ENhanced Treatment of CHF, Unresponsive to Medical Therapy (MOMENTUM) trial began in September of this year.

"We've worked with the FDA to develop an effective protocol for the MOMENTUM trial and are gratified that we can now ramp up to a full complement of sites," said Marvin A. Konstam, M.D., Medical Director of Orqis Medical and Chief of Cardiology at Tufts-New England Medical Center in Boston. "This puts us yet another step closer to our goal of documenting the value that the Cancion therapy can bring to patients with heart failure."

Heart failure is the deterioration of the heart's ability to pump blood throughout the body and adequately perfuse the major organs. According to the AHA, some five million Americans have heart failure and an additional 550,000 are diagnosed annually. The single most expensive diagnosis in the U.S. health care system, acutely decompensated heart failure, represents 1 million primary and 2.5 million secondary hospital admissions annually.

About The Cancion CRS Therapy
A breakthrough discovery in hemodynamics -- the simple supplementation of blood flow specifically in the descending aorta -- led to the development of the Cancion CRS therapy, which centers on the novel use of a blood pump and proprietary peripheral access to the circulatory system.

The Cancion CRS increases blood flow in the descending aorta without t
'"/>

Contact: Kimberly Goolsby
kimberly@goolsbygroup.com
949-464-0187
Goolsby Group
10-Jan-2005


Page: 1 2

Related medicine news :

1. New data on Orqis Medicals Cancion CRS to be reported at ACC
2. UIC professor receives international humanitarian award
3. Mailman School of Public Health receives Manhattan Tobacco Cessation Center grant
4. Epidemiologist Trichopoulos receives $5.8 million Department of Defense Innovator Award
5. GlaxoSmithKline receives unanimous favorable recommendation by FDA Advisory Committee for Boostrix
6. NYU Child Study Center receives grant from the American Red Cross September 11 recovery program
7. Northwestern Memorial Hospital receives $10 million commitment to support preeminent heart program
8. American Academy of Neurology program receives Grassroots Award
9. Mayo Clinic Cancer Center receives SPORE grant for brain cancer research from NCI
10. Pfizers antifungal medicine VFEND receives FDA approval
11. Shire receives US FDA approval of EQUETRO (TM) for bipolar disorder

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:7/22/2020)... ... July 22, 2020 , ... ... of its new Data Curation as a Service (DCaaS) solution for payers, providers, ... on specific clinical data curation parameters and are custom tailored to provide clients ...
(Date:7/18/2020)... ... July 17, 2020 , ... “Frozen.” It’s not simply the title of a ... for unknown reasons – resulting in stiffness, persistent pain and loss of range of ... problems of the upper limbs and joints and founder and chief medical officer of ...
(Date:7/18/2020)... , ... July 17, 2020 , ... ... life, Isagenix International is evolving its brand. While the global company ... holistic approach that supports physical, emotional, and spiritual wellbeing. The company announced the ...
(Date:7/10/2020)... LOS ANGELES (PRWEB) , ... July 10, 2020 ... ... EndPandemics on June 16th, 2020 that, in line with Circularity Healthcare’s mission to ... to protect and regenerate nature and to help prevent future pandemics by ending ...
(Date:7/10/2020)... ... July 10, 2020 , ... Worries and anxiety about ... or injury and social distancing makes it even more challenging. "For folks with ... distress, and PTSD amongst our adult population and children alike," states Greg Jamian, ...
Breaking Medicine News(10 mins):
(Date:7/7/2020)... , ... July 07, 2020 , ... To support those ... of Global Change (WGC), will be providing meals to the employees of Southern Nevada ... testing sites throughout Las Vegas on Wednesday, July 8th. , When asked why the ...
(Date:7/7/2020)... ... , ... SupplyPro announces a Contact Tracing function available on its advanced inventory ... us. SupplyPro is dedicated to supporting the worldwide response to COVID-19. Recent updates to ... powerful tool in the fight against the spread of COVID-19. , Knowing who ...
(Date:7/4/2020)... ... July 03, 2020 , ... With ... to welcome visitors at approved capacities, reactivating the state's economy. The government health ... preventive actions. , The most recent opening was beautiful Hacienda Tres Ríos Resort, ...
Breaking Medicine Technology:
Cached News: